novel tobacco products The European Respiratory Society updated position on nicotine and products, their role in tobacco control and “harm reduction” - ERS ERS updates position statement on

ERS updates position statement on novel nicotine and tobacco products alongside UK clamp down Hospital Healthcare Europe Non Cigarette Tobacco Products and POS Policies Counter Tobacco Frontiers Nicotine and novel tobacco products drive adverse cardiac remodeling and dysfunction in preclinical studies ERS has issued an updated position statement on novel nicotine and tobacco products, maintaining that it cannot recommend harm reduction as a population based strategy to reduce smoking and aid quitting Read the Novel products, misleading information threaten to undo decades of gains against tobacco use PAHO WHO Pan American Health Organization

SKU: 2782235257 · From creatorsinfotech.com